Table 1. Baseline data of patients.
| Parameters | Patients (n=92) |
|---|---|
| Age (years) | 43.5±16.2 |
| Gender (male/female) | 75/17 |
| History of hepatitis, n (%) | 90 (97.8) |
| HBV | 83 (90.2) |
| HCV | 6 (6.5) |
| HBV and HCV, n (%) | 1 (1.0) |
| No history of hepatitis, n (%) | 2 (2.1) |
| Child-Pugh stage, n (%) | |
| A | 62 (67.4) |
| B | 30 (32.6) |
| ECOG performance status, n (%) | |
| 0 | 75 (81.5) |
| 1 | 17 (18.4) |
| BCLC clinical stages, n (%) | |
| A | 45 (48.9) |
| B | 47 (51.0) |
| Tumor distribution, n (%) | |
| Single lesion | 43 (46.7) |
| Multiple lesions | 49 (53.3) |
| Tumor size (cm) | 6.4±2.3 |
| Previous treatments, n (%) | |
| Surgery | 21 (22.8) |
| No treatment | 71 (77.1) |
Data are presented as mean ± standard deviation, median (25th–75th) or count (%). ECOG, Eastern Cooperative Oncology Group; BCLC, Barcelona Clinic Liver Cancer BCLC, Barcelona Clinic Liver Cancer.